About Midatech Ltd/
the Midatech Group

Midatech is at the forefront of designing, developing, synthesizing and manufacturing nanomedicines based on its proprietary, self assembling biocompatible nanoparticle technology.

The company has successfully employed its nanotechnology platform and know-how to transition discovery and engineering sciences to practical nanomedicine applications through in-house and partnered drug development programs. Midatech’s unique nanoparticles allow rapid targeting of drugs or drug combinations to specific tissues or cells as well as potentially enabling transport across the blood brain barrier.

Midatech’s mission is to become the global leader and centre of competence in the nanomedicine arena.

Midatech is a privately-owned Group of Companies with a strong patent estate.

return to homepage…

Events

SACHS European Life Science CEO Forum for Partnering & Investing

March 6 – March 7, 2012, Zurich, Switzerland: attendance and presentation has been confirmed

5th European CLINAM conference for clinical nanomedicine

May 7 – May 9, 2012, Basel, Switzerland: attendance and presentation has been confirmed